Stem Cell Therapy Market
Stem Cell Therapy Market - Global Industry Assessment & Forecast
#
Pages:
143
Base Year:
2022
Aug - 2023
Format:
Report Code:
VMR-2236
Segments Covered
By
Type Allogeneic, Autologous
-
By
Cell Source Adipose Tissue-derived MSCs (Mesenchymal Stem Cells), Bone Marrow-derived MSCs, Others Cell Sources
-
By
Therapeutic Application Musculoskeletal Disorders, Wounds & Injuries, Surgeries, Inflammatory & Autoimmune Diseases, Neurological Disorders, Other Therapeutic Applications
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 235.4 Million |
 Revenue 2030:
|
USD 831.9 Million |
 Revenue CAGR
(2023 - 2030): |
17.2% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Stem Cell Therapy Market Segment Analysis
- Stem Cell Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Allogeneic
- Autologous
- Stem Cell Therapy Cell Source Outlook (Revenue, USD Million, 2018 - 2030)
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Stem Cell Therapy Therapeutic Application Outlook (Revenue, USD Million, 2018 - 2030)
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
-
North America Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
-
North America Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- U.S.
- U.S. Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- U.S. Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- U.S. Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- U.S. Stem Cell Therapy Market, by Type
- Canada
- Canada Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Canada Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Canada Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Canada Stem Cell Therapy Market, by Type
-
Mexico
- Mexico Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Mexico Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Mexico Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Mexico Stem Cell Therapy Market, by Type
-
North America Stem Cell Therapy Market, by Type
- Europe
-
Europe Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
-
Europe Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
-
Europe Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- U. K.
- U.K. Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- U.K. Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- U.K. Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- U.K. Stem Cell Therapy Market, by Type
- France
- France Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- France Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- France Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- France Stem Cell Therapy Market, by Type
-
Germany
- Germany Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Germany Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Germany Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Germany Stem Cell Therapy Market, by Type
-
Italy
- Italy Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Italy Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Italy Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Italy Stem Cell Therapy Market, by Type
-
Spain
- Spain Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Spain Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Spain Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Spain Stem Cell Therapy Market, by Type
-
Rest of Europe
- Rest of Europe Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Rest of Europe Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Rest of Europe Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Rest of Europe Stem Cell Therapy Market, by Type
-
Europe Stem Cell Therapy Market, by Type
- Asia Pacific
-
Asia Pacific Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
-
Asia Pacific Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
-
Asia Pacific Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- China
- China Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- China Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- China Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- China Stem Cell Therapy Market, by Type
- Japan
- Japan Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Japan Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Japan Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Japan Stem Cell Therapy Market, by Type
-
Germany
- Germany Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Germany Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Germany Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Germany Stem Cell Therapy Market, by Type
-
India
- India Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- India Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- India Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- India Stem Cell Therapy Market, by Type
-
South Korea
- South Korea Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- South Korea Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- South Korea Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- South Korea Stem Cell Therapy Market, by Type
-
South East Asia
- South East Asia Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- South East Asia Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- South East Asia Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- South East Asia Stem Cell Therapy Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Rest of Asia Pacific Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Rest of Asia Pacific Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Rest of Asia Pacific Stem Cell Therapy Market, by Type
-
Asia Pacific Stem Cell Therapy Market, by Type
- Latin America
-
Latin America Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
-
Latin America Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
-
Latin America Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Brazil
- Brazil Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Brazil Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Brazil Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Brazil Stem Cell Therapy Market, by Type
- Argentina
- Argentina Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Argentina Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Argentina Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Argentina Stem Cell Therapy Market, by Type
-
Rest of Latin America
- Rest of Latin America Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Rest of Latin America Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Rest of Latin America Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Rest of Latin America Stem Cell Therapy Market, by Type
-
Latin America Stem Cell Therapy Market, by Type
- Middle East & Africa
-
Middle East & Africa Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
-
Middle East & Africa Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
-
Middle East & Africa Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- GCC Countries
- GCC Countries Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- GCC Countries Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- GCC Countries Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- GCC Countries Stem Cell Therapy Market, by Type
- South Africa
- South Africa Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- South Africa Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- South Africa Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- South Africa Stem Cell Therapy Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Stem Cell Therapy Market, by Type
- Allogeneic
- Autologous
- Rest of Middle East & Africa Stem Cell Therapy Market, by Cell Source
- Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- Bone Marrow-derived MSCs
- Others Cell Sources
- Rest of Middle East & Africa Stem Cell Therapy Market, by Therapeutic Application
- Musculoskeletal Disorders
- Wounds & Injuries
- Surgeries
- Inflammatory & Autoimmune Diseases
- Neurological Disorders
- Other Therapeutic Applications
- Rest of Middle East & Africa Stem Cell Therapy Market, by Type
-
Middle East & Africa Stem Cell Therapy Market, by Type
- North America
Vantage Market
Research | 10-Aug-2023
FAQ
Frequently Asked Question
What is the global demand for Stem Cell Therapy in terms of revenue?
-
The global Stem Cell Therapy valued at USD 235.4 Million in 2022 and is expected to reach USD 831.9 Million in 2030 growing at a CAGR of 17.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Advanced Cell Technology Inc. (U.S.), Caladrius Biosciences (U.S.), Angel Biotechnology (Scotland), Bioheart Inc. (U.S.), Brainstorm Cell Therapeutics (U.S.), Celgene Corporation (U.S.), Cellartis AB (Sweden), CellGenix GmbH (Germany), Cellular Engineering Technologies Inc. (U.S.), Gamida Cell (Israel), Genea Biocells (U.S.), Osiris Therapeutics (U.S.), PromoCell GmbH (Germany), STEMCELL Technologies Inc. (Canada), Tigenix Waisman Biomanufacturing (U.S.), Kite Pharma (U.S.), Lonza (Switzerland).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 17.2% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Stem Cell Therapy include
- Availability of Funding for stem cell research
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Stem Cell Therapy in 2022.
